Gurnet Point Capital
Pre-Seed–Seed · 3 people tracked
Find your way into Gurnet Point Capital
Each arrow is one introduction. Sign up to fill in the first one.
Ask Yusuke Okada to introduce you to Michael Bucella
You →Yusuke · together at Neoclassic Capital →Michael
Ask Jamie Chen to introduce you to Sally Tennant
You →Jamie · together at Acorn Capital Advisers →Sally
Ask Sam Okafor to introduce you to Matheus Bonifácio
You →Sam · together at Kli Capital →Matheus
Sign up to find every way you can get introduced to Gurnet Point Capital
- Your email: who you already know at Gurnet Point Capital, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Gurnet Point Capital team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
B-FLEXION invests across transformative industries with a particular focus on life sciences. The firm conducts seed investments, acquires operating businesses, and develops strategic partnerships while maintaining a dedicated practice for biopharma, diagnostics, and innovative healthcare service providers.
Source: firm website, verified Jul 21, 2026.
Team · 3 people
from curatedWhat they invest in
from 4 of 4 portfolio companiesBiotech ×4Healthtech ×2Data & Infrastructure ×1Digital Health ×1Medical Devices ×1
HQs:United States×4
Investments · 4 tracked
founders shown can be your intro pathBy year:2022 · 12018 · 12016 · 12012 · 14 dated
BiotechWatertown, US
Edward Mascioli(Executive Officer)Andrew Myers(Director)
BoardMarkus Goebel(Director)Henry Skinner(Director)inVikas Goyal(Director)Raj Parekh(Director)in
Co-investorsAdvent Life SciencesNovartis Venture FundRoche Venture Fund
Naveris develops and commercializes liquid biopsy tests for the early detection and monitoring of HPV-associated cancers, particularly head and neck and anal cancers.
BiotechData & InfrastructureDigital HealthHealthtechMedical DevicesWaltham, US
James McNally(Executive Officer, Director)inPiyush Gupta(Executive Officer, Director)
BoardAnne Stone(Director)Francis Crispino(Director)Philip Grahame Haydon(Director)
Co-investorsBrightEdgeTechU Ventures
Tremeau develops non-opioid pain therapies for patient populations with high unmet medical needs.
BiotechHealthtechCambridge, US
Bradford C. Sippy(Executive Officer, Director)Benjamin Enerson(Executive Officer)Mark Corrigan(Executive Officer)in
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Frequently asked questions
- What stage does Gurnet Point Capital invest at?
- Gurnet Point Capital invests at the Pre-Seed, Seed stages.
- What sectors does Gurnet Point Capital focus on?
- Gurnet Point Capital focuses on Biotech, Healthtech, Medical Devices, Sector Agnostic.
Similar investors
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Investinor AS is a Norwegian investment company that partners with founders, entrepreneurs and other investors to help selected promising companies become world-leading.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.













.jpeg)
